Research Statement
Dr. Kilbride's scholarship addresses the ethical, legal, and social implications (ELSI) of genetics and genomics, with a focus on direct-to-consumer (DTC) genetic testing. Her current research is supported by a K01 Career Development Award from the National Human Genome Research Institute (NHGRI). In addition to her ELSI work, Dr. Kilbride is also interested in ethical questions related to the physician-patient relationship and gatekeeping in medicine.
Research Keywords
- Genetic Testing
- Direct-to-consumer
- Biomedical Ethics
Publications
- Kilbride M, Egleston BL, Chung WK, Olopade O, Maxwell KN, Shah P, Churpek JE, Fleisher L, Terry MB, Fetzer D, Gaieski JB, Bulafka J, Espinal A & Karpink K (2023). Uptake of Genetic Research Results and Patient-Reported Outcomes With Return of Results Incorporating Web-Based Predisclosure Education. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Vol. 41, 490549154905-4915. Published, 10/01/2023.
- Madison Kilbride, Steven Joffe & Holly Fernandez Lynch (2022). FDA-approved drugs should be over-the-counter by default. Philadelphia Inquirer. Published, 09/06/2022.